The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
December 12th 2024
The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
19th Annual New York Lung Cancers Symposium®
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Is PET/CT Better than CT for Monitoring Metastatic Breast Cancer Treatment?
April 10th 2023A recent prospective study found that progression-free survival (PFS) and disease-specific survival (DSS) were significantly associated with breast cancer tumor treatment response on 2-(18F)FDG-PET/CT imaging in comparison to contrast-enhanced computed tomography (CT), which showed no evidence of a significant association with tumor response.
Can AI Improve Triage of CT Pulmonary Angiography Exams for Acute PE?
April 7th 2023A recent study showed that artificial intelligence (AI)-based worklist reprioritization led to a mean reduction of 12.3 minutes in radiology report turnaround time for positive computed tomography pulmonary angiography (CTPA) exams that were positive for pulmonary embolism.
Study Finds Low Use of LDCT Among Eligible Candidates for Lung Cancer Screening
March 30th 2023A retrospective review of insurance claim data from over one million people eligible for lung cancer screening with low-dose computed tomography (LDCT) found that less than five percent were screened.
What a Chest CT Study Reveals About Ground-Glass Opacities and Recurrence with Lung Adenocarcinoma
March 27th 2023In a study of over 1,000 patients who had surgery for invasive lung adenocarcinoma, researchers found that solid adenocarcinoma on pre-op CT imaging was associated with more than double the risks of recurrence and brain metastasis in patients with clinical stage I disease in comparison to ground-glass opacity (GGO) adenocarcinoma.
Seven Takeaways from Best Practice Recommendations for Incidental Radiology Findings in the ER
March 14th 2023Noting that computed tomography (CT) scans are obtained for more than 30 million emergency department (ED) patients annually and that 31.3 percent of ED CT scans reveal incidental findings, representatives from the American College of Radiology (ACR) and the American College of Emergency Physicians (ACEP) recently collaborated on best practice recommendations for addressing incidental imaging findings in EDs.
New Chest CT Study Assesses Impact of COVID-19 Variants and Vaccination Status
March 8th 2023Emerging research from a multicenter study found that COVID-19 vaccination was affiliated with a lower likelihood of high computed tomography (CT) severity scores and typical CT findings for COVID-19 in comparison to unvaccinated patients.
Should Dual-Source CT be the New Standard for ER CCTA Assessment of Acute Chest Pain?
March 3rd 2023Recently published research revealed that coronary computed tomography angiography (CCTA) exams performed with dual-source CT were completed 22 minutes faster and had a nearly 28 percent higher frequency of good or excellent image quality in comparison to CCTA exams performed with single-source CT devices.
Canon Medical Launches New CT and X-Ray Modalities at ECR 2023
March 2nd 2023The new launches include the 80/160-slice computed tomography (CT) scanner Aquilion Serve, which allows simultaneous previews of axial, lateral and AP views, and Celex, a multipurpose X-ray system that offers automated and customizable features to help maximize workflow efficiencies.
Cancer Screenings and COVID-19: What a New Study Shows
February 27th 2023New research from the American Cancer Society comparing pre-pandemic cancer screening prevalence to the second year of the COVID-19 pandemic in the United States showed a 1.1 million decrease in breast cancer screenings, a 4.4 million decrease in cervical cancer screening and a 600,000 decrease in prostate cancer screenings.
AI/CT Combination for Assessing Pulmonary Embolism Severity Gets FDA Nod
February 23rd 2023Facilitating expedited assessment of pulmonary embolism severity, the emerging artificial intelligence (AI) tool Rapid RV/LV reportedly calculates the right ventricle/left ventricle (RV/LV) ratio within minutes of a computed tomography pulmonary angiogram (CTPA).
Can a New AI Tool Improve Detection of Incidental Pulmonary Embolism on CT?
February 22nd 2023Noting that only 25 percent of incidental emboli are identified in reporting of initial computed tomography (CT) exams, Avicenna.AI said the artificial intelligence (AI)-enabled CINA-iPE is geared toward detecting incidental pulmonary embolism (PE) on chest CT scans.
Is Follow-Up Pelvic CT Coverage Necessary for Patients Treated for Hepatocellular Carcinoma?
February 22nd 2023Noting that pelvic coverage can increase radiation dosing for liver computed tomography (CT) by 29 to 39 percent, researchers found low three-year cumulative rates of incidental pelvic tumors and isolated pelvic metastasis in follow-up liver CT imaging of over 1,100 people treated for hepatocellular carcinoma.
How Accurate is the CT Severity Score for Predicting COVID-19 Severity?
February 17th 2023The computed tomography severity score (CTSS) has sensitivity rates of 85 percent for predicting the severity of COVID-19 and 77 percent for predicting COVID-19 related mortality, according to a newly published meta-analysis.